Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
16 September 2020 | Story Xolisa Mnukwa | Photo Supplied
UFS Division of Student Affairs plans to extend their annual research colloquium to involve other universities, establishing the university as a pioneering institution of higher education and learning.
The annual University of the Free State (UFS) Division of Student Affairs Research (DSA) Colloquium aims to promote a culture of research embedded in data-driven and evidence- based practices in the field of Student Affairs. The purpose of the annual colloquium is to create a safe, enjoyable space for staff members to share their experiences, knowledge, research and practices.

The 2020 Student Affairs Research Colloquium was the first virtual Research Colloquium held by the university. As noted by DSA Researcher Ruben Langenhoven, this year’s theme Virtually Human: Connecting Meaningfully in a Digital World was inspired by the challenging times we live in, and thus commemorated the resilience and adaptability UFS Student Affairs practitioners, academic staff and students. 

As most of the projects and programmes in the DSA were negatively impacted, the Colloquium was threatened by a lack of “hard data” emanating from the 2020 academic year. The division consequently decided to reframe the colloquium by profiling distinct human voices that focused on qualitative experiences. As such, this Colloquium comprised of numerous sections where the emphasis was placed on shared experiences and shared understanding where UFS staff members and students discussed the challenges they faced in the last six months.

DSA staff engaged one another with staff and student-centered lived experiences, and professional staff development sessions that visited the impact of technology on their psychological well-being and how to improve their relationship with technology in light of the COVID-19 pandemic. Also forming part of the programme that will inform the future of the division going forward, reflected DSA success-story presentations of the past year. 

The colloquium proved as beneficial for the DSA and the entire institution in its pursuit of a research-based working approach within the Student Affairs discipline. 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk. Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept